Literature DB >> 33406391

T Cell Memory: Understanding COVID-19.

Nicholas N Jarjour1, David Masopust2, Stephen C Jameson3.   

Abstract

As the SARS-CoV-2 pandemic has progressed, increasing attention has focused on establishing natural and vaccine-induced immunity against this coronavirus and the disease, COVID-19, that it causes. In this Primer, we explain the fundamental features of T cell memory and their potential relevance for effective immunity to SARS-CoV-2.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33406391     DOI: 10.1016/j.immuni.2020.12.009

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  42 in total

1.  Cutting Edge: Lung-Resident T Cells Elicited by SARS-CoV-2 Do Not Mediate Protection against Secondary Infection.

Authors:  Lydia M Roberts; Forrest Jessop; Tara D Wehrly; Catharine M Bosio
Journal:  J Immunol       Date:  2021-10-04       Impact factor: 5.422

2.  Immune signatures underlying post-acute COVID-19 lung sequelae.

Authors:  I S Cheon; C Li; Y M Son; N P Goplen; Y Wu; T Cassmann; Z Wang; X Wei; J Tang; Y Li; H Marlow; S Hughes; L Hammel; T M Cox; E Goddery; K Ayasoufi; D Weiskopf; J Boonyaratanakornkit; H Dong; H Li; R Chakraborty; A J Johnson; E Edell; J J Taylor; M H Kaplan; A Sette; B J Bartholmai; R Kern; R Vassallo; J Sun
Journal:  Sci Immunol       Date:  2021-11-12

3.  Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone.

Authors:  Bashir Lawal; Yu-Cheng Kuo; Maryam Rachmawati Sumitra; Alexander T H Wu; Hsu-Shan Huang
Journal:  Comput Biol Med       Date:  2022-07-11       Impact factor: 6.698

4.  Evaluation of lymphocyte count, T-cell subsets and neutrophil-to-lymphocyte ratio as early predictors for severity and outcome of COVID-19 disease-a report from a highly complex hospital in Brazil.

Authors:  Douglas Câmara de Oliveira; Beatriz Sanada Spiri; Yara Carolina Schluga; Julie Lilian Pimentel Justus; Francisco Diego Negrão Lopes Neto; Ana Paula de Azambuja
Journal:  Hematol Transfus Cell Ther       Date:  2022-06-29

5.  Expansion of cytotoxic tissue-resident CD8+ T cells and CCR6+CD161+ CD4+ T cells in the nasal mucosa following mRNA COVID-19 vaccination.

Authors:  Aloysious Ssemaganda; Huong Mai Nguyen; Faisal Nuhu; Naima Jahan; Catherine M Card; Sandra Kiazyk; Giulia Severini; Yoav Keynan; Ruey-Chyi Su; Hezhao Ji; Bernard Abrenica; Paul J McLaren; T Blake Ball; Jared Bullard; Paul Van Caeseele; Derek Stein; Lyle R McKinnon
Journal:  Nat Commun       Date:  2022-06-10       Impact factor: 17.694

6.  Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003.

Authors:  Wen-Pin Tseng; Jhong-Lin Wu; Chen-Chi Wu; Kuan-Ting Kuo; Chien-Hao Lin; Ming-Yi Chung; Ya-Fan Lee; Bey-Jing Yang; Chien-Hua Huang; Shey-Ying Chen; Chong-Jen Yu; Shyr-Chyr Chen; Po-Ren Hsueh
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

Review 7.  Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature.

Authors:  Marcial Delgado-Fernández; Gracia Mar García-Gemar; Ana Fuentes-López; Manuel Isidro Muñoz-Pérez; Salvador Oyonarte-Gómez; Ignacio Ruíz-García; Jessica Martín-Carmona; Jaime Sanz-Cánovas; Manuel Ángel Castaño-Carracedo; José María Reguera-Iglesias; Juan Diego Ruíz-Mesa
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2021-02-11

Review 8.  Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2.

Authors:  Pankaj Ahluwalia; Kumar Vaibhav; Meenakshi Ahluwalia; Ashis K Mondal; Nikhil Sahajpal; Amyn M Rojiani; Ravindra Kolhe
Journal:  Front Immunol       Date:  2021-05-11       Impact factor: 7.561

9.  The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro.

Authors:  Jinglu Lyu; Lirong Bao; Xin Shen; Caixia Yan; Cheng Zhang; Wei Wei; Yutao Yang; Jia Li; Jiajia Dong; Liying Xiao; Xuedong Zhou; Yan Li
Journal:  Int Immunopharmacol       Date:  2021-05-19       Impact factor: 5.714

10.  Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants.

Authors:  Graham Pawelec; Emilie Picard
Journal:  Signal Transduct Target Ther       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.